DLGAP1 and gastric cancer: Ultimately, we established the DLGAP1-AS1/miR-203a-3p/THBS2 ceRNA pathway, which was not only significantly associated with the prognosis of GC patients but also played pivotal roles in the progression of GC (Supplementary Figure 5A–5C).